Home › Funds › UBS Group AG › GLTO
UBS Group AG position in GLTO
DAMORA THERAPEUTICS INC
Latest position (Q2 2026)840.29K sh
Reported value held$21.86M
Portfolio Weight0.00%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 6.74K | $20.00K | New |
| Q1 2022 | 2.50K | $5.00K | Reduce |
| Q3 2022 | 4.10K | $8.00K | New |
| Q1 2023 | 2.48K | $4.94K | New |
| Q3 2023 | 7.09K | $5.10K | New |
| Q4 2023 | 4.28K | $3.08K | Reduce |
| Q3 2024 | 5.10K | $61.95K | New |
| Q4 2024 | 12.47K | $57.97K | Add |
| Q1 2025 | 285 | $883 | Reduce |
| Q2 2025 | 2.31K | $7.89K | Add |
| Q3 2025 | 59 | $220 | Reduce |
| Q4 2025 | 6.39K | $147.01K | Add |
| Q1 2026 | 160.41K | $4.15M | Add |
| Q2 2026 | 840.29K | $21.86M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding GLTO
- Fidelity Management & Research (FMR) 9.23M sh · $240.15M · Q2 2026
- BlackRock Inc 3.16M sh · $82.25M · Q2 2026
- Viking Global Investors 2.31M sh · $60.11M · Q2 2026
- JPMorgan Chase & Co 2.06M sh · $49.85M · Q2 2026
- Balyasny Asset Management 1.23M sh · $31.97M · Q2 2026
- Wellington Management Group 1.06M sh · $27.52M · Q2 2026
- Geode Capital Management 965.36K sh · $25.11M · Q2 2026
- Northern Trust Corp 359.70K sh · $9.36M · Q2 2026
- Goldman Sachs Group 339.38K sh · $8.83M · Q2 2026
- Citadel Advisors 166.35K sh · $4.33M · Q2 2026
- BNY Mellon 151.02K sh · $3.93M · Q2 2026